Analysis and pharmacological modulation of senescence in human epithelial stem cells
- PMID: 35706382
- PMCID: PMC9279594
- DOI: 10.1111/jcmm.17434
Analysis and pharmacological modulation of senescence in human epithelial stem cells
Abstract
Human epithelial stem cells (ESCs) are characterized by long-term regenerative properties, much dependent on the tissue of origin and varying during their lifespan. We analysed such variables in cultures of ESCs isolated from the skin, conjunctiva, limbus and oral mucosa of healthy donors and patients affected by ectrodactyly-ectodermal dysplasia-clefting syndrome, a rare genetic disorder caused by mutations in the p63 gene. We cultured cells until exhaustion in the presence or in the absence of DAPT (γ-secretase inhibitor; N-[N-(3, 5-difluorophenacetyl)-L-alanyl]-S-phenylglycine T-butyl ester). All cells were able to differentiate in vitro but exhibited variable self-renewal potential. In particular, cells carrying p63 mutations stopped prematurely, compared with controls. Importantly, administration of DAPT significantly extended the replicative properties of all stem cells under examination. RNA sequencing analysis revealed that distinct sets of genes were up- or down-regulated during their lifetime, thus allowing to identify druggable gene networks and off-the-shelf compounds potentially dealing with epithelial stem cell senescence. These data will expand our knowledge on the genetic bases of senescence and potentially pave the way to the pharmacological modulation of ageing in epithelial stem cells.
Keywords: DAPT (γ-secretase inhibitor; N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine T-butyl ester); EEC syndrome; RNAseq; lifespan; p63; self-renewal; stem cells.
© 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Conflict of interest statement
The authors confirm that there are no conflicts of interest.
Figures









Similar articles
-
Personalized Stem Cell Therapy to Correct Corneal Defects Due to a Unique Homozygous-Heterozygous Mosaicism of Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.Stem Cells Transl Med. 2016 Aug;5(8):1098-105. doi: 10.5966/sctm.2015-0358. Epub 2016 May 5. Stem Cells Transl Med. 2016. PMID: 27151912 Free PMC article.
-
Correction of Mutant p63 in EEC Syndrome Using siRNA Mediated Allele-Specific Silencing Restores Defective Stem Cell Function.Stem Cells. 2016 Jun;34(6):1588-600. doi: 10.1002/stem.2343. Epub 2016 Mar 16. Stem Cells. 2016. PMID: 26891374
-
Limbal stem cell deficiency and ocular phenotype in ectrodactyly-ectodermal dysplasia-clefting syndrome caused by p63 mutations.Ophthalmology. 2012 Jan;119(1):74-83. doi: 10.1016/j.ophtha.2011.06.044. Epub 2011 Sep 28. Ophthalmology. 2012. PMID: 21959367
-
p63 in corneal and epidermal differentiation.Biochem Biophys Res Commun. 2022 Jun 25;610:15-22. doi: 10.1016/j.bbrc.2022.04.022. Epub 2022 Apr 9. Biochem Biophys Res Commun. 2022. PMID: 35430447 Review.
-
Ankyloblepharon-ectodermal dysplasia-clefting syndrome misdiagnosed as epidermolysis bullosa and congenital ichthyosiform erythroderma: Case report and review of published work.J Dermatol. 2019 May;46(5):422-425. doi: 10.1111/1346-8138.14837. Epub 2019 Feb 27. J Dermatol. 2019. PMID: 30809829 Review.
Cited by
-
Changes in Telomere Length in Leukocytes and Leukemic Cells after Ultrashort Electron Beam Radiation.Int J Mol Sci. 2024 Jun 18;25(12):6709. doi: 10.3390/ijms25126709. Int J Mol Sci. 2024. PMID: 38928414 Free PMC article.
-
Innovative Therapeutic Approaches for the Treatment of the Ocular Morbidities in Patients with EEC Syndrome.Cells. 2023 Feb 2;12(3):495. doi: 10.3390/cells12030495. Cells. 2023. PMID: 36766837 Free PMC article. Review.
References
-
- Das D, Fletcher RB, Ngai J. Cellular mechanisms of epithelial stem cell self‐renewal and differentiation during homeostasis and repair. Wiley Interdisciplinary Rev Dev Biol. 2020;9:e361. - PubMed
-
- Rowat JS, Squier CA. Rates of epithelial cell proliferation in the oral mucosa and skin of the tamarin monkey (Saguinus fuscicollis). J Dent Res. 1986;65:1326‐1331. - PubMed
-
- Gibbs S, Ponec M. Intrinsic regulation of differentiation markers in human epidermis, hard palate and buccal mucosa. Arch Oral Biol. 2000;45:149‐158. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical